Navigation Links
Nasseo, Inc. Joins BioInspire™ Medical Technology Incubator, Closes Seed Funding Round
Date:2/15/2013

San Diego, CA (PRWEB) February 15, 2013

Nasseo, Inc., a medical device company based in San Diego, CA, is pleased to announce that it has closed its $520K seed financing round. BioInspire™, a medical technology incubator that funded Nasseo earlier this year, leads the round along with an internationally renowned dentist. The Nasseo TiArray™ dental implant system, the first product based on Nasseo’s proprietary implant surface modification technology, has been developed for diabetics and smokers with poor bone healing who are seeking dental implants but have limited treatment options with today’s technology. Nasseo offers dentists cost-effective, high quality, and easy-to-use implants that significantly improve clinician productivity and expand patient care options.

BioInspire™ is a collaborative partnership between BioAccel®, Plaza Companies, and the City of Peoria, Arizona, that provides working capital and space to those companies selected and admitted per its application criteria. BioInspire™ focuses on directly addressing the challenges of commercializing medical devices by providing portfolio companies with assistance in funding, partnerships and mentorship.

Dr. Garrett Cale Smith, Co-Founder and CEO of Nasseo, says, “We are honored to be selected as a BioInspire™ portfolio company and to be identified as a medtech company that is poised for investment based upon the unmet clinical need that our enabling technology is addressing.”

Nasseo’s technology has received increasingly enthusiastic reception from members across diverse sectors of the scientific and investment community. Most recently, Nasseo participated in World’s Best Technology (WBT) Innovation Marketplace 2012, the premier showc
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Robert Storey Joins VIC Technology Venture Development as Executive in Residence
2. Michael Berman Joins InspireMD Board
3. Rudy Mazzocchi Joins the Greatbatch Board of Directors as he Continues to Expand his Presence in the Med-tech Industry
4. Diabetes Research Institute Foundation’s (DRIF) CEO Joins Healthcare Holdings Group, Inc. Board of Directors
5. IntelliCell BioSciences Announces Michael Hershman Joins the IntelliCell BioSciences Board of Directors
6. Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
7. John A. Orwin Joins Array BioPharma Board Of Directors
8. IntelliCell BioSciences Announces Myron Z. Holubiak Joins the IntelliCell BioSciences Board of Directors
9. MD Anderson Cancer Center joins Actinium Pharmaceuticals (API) Multicenter Actimab-A Trial
10. Walgreens Joins with Ferring Pharmaceuticals Inc. to Offer Products and Resources to Women Facing Fertility Complications from Cancer Treatment
11. Northwestern University Joins VIVO Network with Elseviers SciVal Experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/11/2014)... a one atom thick sheet of carbon, can be ... form of graphene that could have a significant impact ... paint, it could provide an ultra-strong, non-corrosive coating for ... oxide solutions can be used to paint various surfaces ... After a simple chemical treatment, the resulting coatings behave ...
(Date:9/11/2014)... 11, 2014 XBiotech announced today it has ... that the Company says will be used to dramatically ... is designed to fill, stopper and crimp vials, which ... the unit is said to contain an in-line feed ... a high level of quality compared to less sophisticated ...
(Date:9/11/2014)... 2014 The Registration Committee today ... now open for Pittcon 2015, the world’s largest ... event will be held March 8-12, 2015, at ... , The discounted registration fee of $175 ... 2/20/2015). This affordable price includes unlimited week-long access ...
(Date:9/11/2014)... (PRWEB) September 11, 2014 CollabRx, ... and IT systems that support clinical decision-making in ... Service that now supports the interpretation of copy ... a single, user-friendly report that contains clinically relevant ... toward cancer treatment planning and support of clinical ...
Breaking Biology Technology:Graphene paints a corrosion-free future 2Conferee Registration Opens for Pittcon 2015; Housing & Travel Open for Reservations 2CollabRx Launches Expansion of Its Genetic Variation Annotation Service to Support Copy Number Variation (CNV) Data 2CollabRx Launches Expansion of Its Genetic Variation Annotation Service to Support Copy Number Variation (CNV) Data 3
... Aug. 3, 2011 Omeros Corporation (NASDAQ: ... and commercializing products focused on inflammation, bleeding and disorders ... A. Demopulos, M.D., chairman and chief executive officer, is ... 2011 Canaccord Genuity Growth Conference August ...
... 2011 Reportlinker.com announces that a ... in its catalogue: ... - discovering the pharma and diagnostics ... What are the ...
... Inc. (Nasdaq: ANDS ) announced today that it ... 8, 2011, after the U.S. financial markets close. ... August 8, 2011, at 5:00 p.m. Eastern Daylight Time to ... live webcast of the call will be available online at ...
Cached Biology Technology:Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 2Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 3Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 4Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 5Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 6Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 7Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 8Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 9Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 10Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 11Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 12Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 13Biomarkers: Technological and Commercial Outlook 2011-2021 - Discovering the Pharma and Diagnostics Opportunities 14Anadys Pharmaceuticals to Report Second Quarter 2011 Financial Results 2
(Date:9/11/2014)... University researchers and their international colleagues have created ... of neutral evolution in the biogeographic distribution of ... in the journal Science . The papertitled ... neutral agent-based model"was co-authored by Ferdi Hellweger, a ... civil and environmental engineering; his doctoral student Neil ...
(Date:9/11/2014)... (Sept. 11, 2014)Scientists today unveiled what appears to be ... aegyptiacus . New fossils of the massive Cretaceous-era predator ... 95 million years ago, providing the most compelling evidence ... hunt in an aquatic environment. The fossils also indicate ... dinosaur to roam the Earth, measuring more than 9 ...
(Date:9/11/2014)... Rice Research Institute of Iran have discovered that ... and Asia, has changed its host preferences in order to ... this adaptation for biological control of problematic weeds in rice ... plant have been described in the open access journal ... G. permixtana have been so far reported to ...
Breaking Biology News(10 mins):Microbes evolve faster than ocean can disperse them 2Scientists report first semiaquatic dinosaur, Spinosaurus 2Scientists report first semiaquatic dinosaur, Spinosaurus 3Scientists report first semiaquatic dinosaur, Spinosaurus 4Unusual host preference of a moth species could be useful for biological control 2
... For millions of Americans with Type-2 diabetes and inject ... associated risk of cancer is of increasing concern. Studies ... produced by the body or injected in synthetic form ... With the release of today,s study, "Supramolecular ...
... University of Illinois scientists have learned that a specific ... health. "In experiments with mice, we knocked out ... body to make arachidonic acid. Without arachidonic acid, the ... itchy, they scratched themselves continuously, and they developed a ...
... More than one third of Americans are considered obese ... mass index (BMI) greater than 40. The April issue of ... on the ever-increasing use of bariatric surgery to control the ... important role that registered dietitians play in the management of ...
Cached Biology News:Case Western Reserve team discovers 'smart' insulin molecule 2U of I study: Lack of omega-6 fatty acid linked to severe dermatitis 2Registered dietitians play essential role in management of gastric bypass patients 2Registered dietitians play essential role in management of gastric bypass patients 3
... expression of an N-terminal FLAG® fusion and ... marker from bicistronic mRNA. Two genes ... for transcription of a single message from ... for protein-protein interaction studies, multi-subunit proteins, and ...
Mouse monoclonal antibody raised against a partial recombinant PRG4. NCBI Entrez Gene ID = PRG4...
Mouse monoclonal antibody raised against a partial recombinant FAAH. NCBI Entrez Gene ID = FAAH...
Mouse monoclonal antibody raised against a partial recombinant ZNF167. NCBI Entrez Gene ID = ZNF167...
Biology Products: